Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (14774)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Feb 14, 2016 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Grassi G, Di Caprio G, Fimia GM, Ippolito G, Tripodi M, Alonzi T. Hepatitis C virus relies on lipoproteins for its life cycle. World J Gastroenterol 2016; 22(6): 1953-1965 [PMID: 26877603 DOI: 10.3748/wjg.v22.i6.1953] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i6/1953.htm |
| Number | Citing Articles |
| 1 |
Chung‐Feng Huang, Chia‐Yen Dai, Ming‐Lun Yeh, Ching‐I Huang, Hsiang‐Chun Lee, Wen‐Ter Lai, Po‐Cheng Liang, Yi‐Hung Lin, Ming‐Yen Hsieh, Nai‐Jen Hou, Zu‐Yau Lin, Shinn‐Cherng Chen, Jee‐Fu Huang, Wan‐Long Chuang, Ming‐Lung Yu. Cure or curd: Modification of lipid profiles and cardio‐cerebrovascular events after hepatitis C virus eradication. The Kaohsiung Journal of Medical Sciences 2020; 36(11): 920 doi: 10.1002/kjm2.12275
|
| 2 |
Darby W. Kozan, Steven A. Farber. Is It Ever Wise to Edit Wild-Type Alleles? Engineered CRISPR Alleles Versus Millions of Years of Human Evolution. Arteriosclerosis, Thrombosis, and Vascular Biology 2024; 44(2): 328 doi: 10.1161/ATVBAHA.123.318069
|
| 3 |
Longbo Hu, Jinqian Li, Hua Cai, Wenxia Yao, Jing Xiao, Yi-Ping Li, Xiu Qiu, Huimin Xia, Tao Peng. Avasimibe: A novel hepatitis C virus inhibitor that targets the assembly of infectious viral particles. Antiviral Research 2017; 148: 5 doi: 10.1016/j.antiviral.2017.10.016
|
| 4 |
Mariana Nogueira Batista, Paulo Ricardo da Silva Sanches, Bruno Moreira Carneiro, Ana Cláudia Silva Braga, Guilherme Rodrigues Fernandes Campos, Eduardo Maffud Cilli, Paula Rahal. GA-Hecate antiviral properties on HCV whole cycle represent a new antiviral class and open the door for the development of broad spectrum antivirals. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-32176-w
|
| 5 |
Jesse JR Masson, Hugh WW Billings, Clovis S Palmer. Metabolic reprogramming during hepatitis B disease progression offers novel diagnostic and therapeutic opportunities. Antiviral Chemistry and Chemotherapy 2017; 25(2): 53 doi: 10.1177/2040206617701372
|
| 6 |
Vladimir Alexei Morozov, Sylvie Lagaye. Hepatitis C virus: Morphogenesis, infection and therapy. World Journal of Hepatology 2018; 10(2): 186-212 doi: 10.4254/wjh.v10.i2.186
|
| 7 |
Georg Peschel, Sabrina Krautbauer, Kilian Weigand, Jonathan Grimm, Marcus Höring, Gerhard Liebisch, Martina Müller, Christa Buechler. Rising Lysophosphatidylcholine Levels Post-Hepatitis C Clearance. International Journal of Molecular Sciences 2024; 25(2): 1198 doi: 10.3390/ijms25021198
|
| 8 |
Chiara Rosso, Gian Paolo Caviglia, Michela Ciruolo, Alessia Ciancio, Ramy Younes, Antonella Olivero, Chiara Giordanino, Giulia Troshina, Maria Lorena Abate, Mario Rizzetto, Rinaldo Pellicano, Giorgio M. Saracco, Elisabetta Bugianesi, Antonina Smedile. Clinical outcomes in chronic hepatitis C long-term responders to pre-direct antiviral agents: a single-center retrospective study. Minerva Medica 2019; 110(5) doi: 10.23736/S0026-4806.19.06108-1
|
| 9 |
Gulsum Ozlem Elpek. Molecular pathways in viral hepatitis-associated liver carcinogenesis: An update. World Journal of Clinical Cases 2021; 9(19): 4890-4917 doi: 10.12998/wjcc.v9.i19.4890
|
| 10 |
Nehal K. Abdel Fattah, Sara M. Shaheen, Osama A. Ahmed, Kadry Elsaeed, Nagwa A. Sabri. Metabolic changes in chronic hepatitis C patients receiving direct acting antivirals. F1000Research 2022; 11: 649 doi: 10.12688/f1000research.109397.1
|
| 11 |
Kaelan Gobeil Odai, Conor O’Dwyer, Rineke Steenbergen, Tyler A. Shaw, Tyler M. Renner, Peyman Ghorbani, Mojgan Rezaaifar, Shauna Han, Marc-André Langlois, Angela M. Crawley, Rodney S. Russell, John P. Pezacki, D. Lorne Tyrrell, Morgan D. Fullerton. In Vitro Hepatitis C Virus Infection and Hepatic Choline Metabolism. Viruses 2020; 12(1): 108 doi: 10.3390/v12010108
|
| 12 |
Abdullah A. Awadh, Subodh Samrat. The Role of Cytosolic Lipid Droplets in Hepatitis C Virus Replication, Assembly, and Release. BioMed Research International 2023; 2023(1) doi: 10.1155/2023/5156601
|
| 13 |
Sandrine Belouzard, Adeline Danneels, Lucie Fénéant, Karin Séron, Yves Rouillé, Jean Dubuisson, J.-H. James Ou. Entry and Release of Hepatitis C Virus in Polarized Human Hepatocytes. Journal of Virology 2017; 91(18) doi: 10.1128/JVI.00478-17
|
| 14 |
Siobhan Gargan, Nigel J. Stevenson. Unravelling the Immunomodulatory Effects of Viral Ion Channels, towards the Treatment of Disease. Viruses 2021; 13(11): 2165 doi: 10.3390/v13112165
|
| 15 |
Thomas Grewal, Christa Buechler. Emerging Insights on the Diverse Roles of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in Chronic Liver Diseases: Cholesterol Metabolism and Beyond. International Journal of Molecular Sciences 2022; 23(3): 1070 doi: 10.3390/ijms23031070
|
| 16 |
Nadine Ahmed, Noreen Ahmed, Roxana Filip, John Paul Pezacki. Nuclear Receptors. 2021; : 315 doi: 10.1007/978-3-030-78315-0_13
|
| 17 |
Tiziana Vescovo, Giulia Refolo, Matteo Ciancio Manuelli, Giuseppe Tisone, Mauro Piacentini, Gian Maria Fimia. The Impact of Mevastatin on HCV Replication and Autophagy of Non-Transformed HCV Replicon Hepatocytes Is Influenced by the Extracellular Lipid Uptake. Frontiers in Pharmacology 2019; 10 doi: 10.3389/fphar.2019.00718
|
| 18 |
Estibaliz Glaría, Nicole A Letelier, Annabel F Valledor. Integrating the roles of liver X receptors in inflammation and infection: mechanisms and outcomes. Current Opinion in Pharmacology 2020; 53: 55 doi: 10.1016/j.coph.2020.05.001
|
| 19 |
Kilian Weigand, Georg Peschel, Jonathan Grimm, Marcus Höring, Sabrina Krautbauer, Gerhard Liebisch, Martina Müller, Christa Buechler. Serum Phosphatidylcholine Species 32:0 as a Biomarker for Liver Cirrhosis Pre- and Post-Hepatitis C Virus Clearance. International Journal of Molecular Sciences 2024; 25(15): 8161 doi: 10.3390/ijms25158161
|
| 20 |
Sonia Roman, Ingrid Rivera-Iñiguez, Claudia Ojeda-Granados, Maricruz Sepulveda-Villegas, Arturo Panduro. Dietary Interventions in Liver Disease. 2019; : 3 doi: 10.1016/B978-0-12-814466-4.00001-X
|
| 21 |
Emilie Crouchet, Thomas F. Baumert, Catherine Schuster. Hepatitis C virus–apolipoprotein interactions: molecular mechanisms and clinical impact. Expert Review of Proteomics 2017; 14(7): 593 doi: 10.1080/14789450.2017.1344102
|
| 22 |
Pin-Nan Cheng, Hung-Yu Sun, I-Che Feng, Yen-Cheng Chiu, Sin-Tian Wang, Dyoness Charmaine Tan, Hung-Chih Chiu, Shih-Chih Chien, Kung-Chia Young. Interdependence of glycemic and lipid modulation in cured chronic hepatitis C patients by direct-acting antiviral agents. Journal of Microbiology, Immunology and Infection 2023; 56(1): 20 doi: 10.1016/j.jmii.2022.06.004
|
| 23 |
Szu-Jen Wang, Chung-Feng Huang, Ming-Lung Yu. Elbasvir and grazoprevir for the treatment of hepatitis C. Expert Review of Anti-infective Therapy 2021; 19(9): 1071 doi: 10.1080/14787210.2021.1874351
|
| 24 |
Noila Talipova, Bakhtiyar Iriskulov, Sevara Azimova, Shakhnoza Latipova, D.V. Rudoy, A.V. Olshevskaya, E.N. Ponomareva, M.Yu. Odabashyan. Genetic characteristics of the course of chronic hepatitis. E3S Web of Conferences 2023; 381: 01098 doi: 10.1051/e3sconf/202338101098
|
| 25 |
Steven W. Johnson, Dorothea K. Thompson, Brianne Raccor. Hepatitis C Virus-Genotype 3: Update on Current and Emergent Therapeutic Interventions. Current Infectious Disease Reports 2017; 19(6) doi: 10.1007/s11908-017-0578-5
|
| 26 |
Claudia Ojeda-Granados, Arturo Panduro, Karina Gonzalez-Aldaco, Ingrid Rivera-Iñiguez, Liliana Campos-Medina, Sonia Roman. Adherence to a Fish-Rich Dietary Pattern Is Associated with Chronic Hepatitis C Patients Showing Low Viral Load: Implications for Nutritional Management. Nutrients 2021; 13(10): 3337 doi: 10.3390/nu13103337
|
| 27 |
Sean A. Burnap, Ana Maria Ortega-Prieto, Jose M. Jimenez-Guardeño, Hashim Ali, Kaloyan Takov, Matthew Fish, Manu Shankar-Hari, Mauro Giacca, Michael H. Malim, Manuel Mayr. Cross-Linking Mass Spectrometry Uncovers Interactions Between High-Density Lipoproteins and the SARS-CoV-2 Spike Glycoprotein. Molecular & Cellular Proteomics 2023; 22(8): 100600 doi: 10.1016/j.mcpro.2023.100600
|
| 28 |
Suchandrima Ghosh, Joyeeta Chakraborty, Avijit Goswami, Sayantani Bhowmik, Susree Roy, Amit Ghosh, Sakshi Dokania, Priyanka Kumari, Simanti Datta, Abhijit Chowdhury, Suvendra Nath Bhattacharyya, Raghunath Chatterjee, Soma Banerjee. A novel microRNA boosts hyper-β-oxidation of fatty acids in liver by impeding CEP350-mediated sequestration of PPARα and thus restricts chronic hepatitis C. RNA Biology 2020; 17(9): 1352 doi: 10.1080/15476286.2020.1768353
|
| 29 |
Sagarika Shahriar, Yusha Araf, Rasel Ahmad, Pravakar Kattel, Ganga Sagar Sah, Tanjim Ishraq Rahaman, Rahila Zannat Sadiea, Shahnaj Sultana, Md. Sayeedul Islam, Chunfu Zheng, Md. Golzar Hossain. Insights Into the Coinfections of Human Immunodeficiency Virus-Hepatitis B Virus, Human Immunodeficiency Virus-Hepatitis C Virus, and Hepatitis B Virus-Hepatitis C Virus: Prevalence, Risk Factors, Pathogenesis, Diagnosis, and Treatment. Frontiers in Microbiology 2022; 12 doi: 10.3389/fmicb.2021.780887
|
| 30 |
Sabine Chapuy-Regaud, Claire Allioux, Nicolas Capelli, Marion Migueres, Sébastien Lhomme, Jacques Izopet. Vectorial Release of Human RNA Viruses from Epithelial Cells. Viruses 2022; 14(2): 231 doi: 10.3390/v14020231
|
| 31 |
Safaa R. Askar, Radwa S. Hagag, Moamen A. Ismail, Heba I. Aly. Metabolic syndrome severity z-score in non-diabetic non-obese Egyptian patients with chronic hepatitis c virus infection. Future Journal of Pharmaceutical Sciences 2024; 10(1) doi: 10.1186/s43094-024-00739-6
|
| 32 |
Howayda E. Gomaa, Mohamed Mahmoud, Nevine E. Saad, Amal Saad-Hussein, Somaia Ismail, Eman H. Thabet, Hebatallah Farouk, Dina Kandil, Ahmed Heiba, Wael Hafez. Impact of Apo E gene polymorphism on HCV therapy related outcome in a cohort of HCV Egyptian patients. Journal of Genetic Engineering and Biotechnology 2018; 16(1): 47 doi: 10.1016/j.jgeb.2017.10.008
|
| 33 |
Manish Dwivedi, Aditya Dwivedi, Debalina Mukherjee. An Insight into Hepatitis C Virus: In Search of Promising Drug Targets. Current Drug Targets 2023; 24(14): 1127 doi: 10.2174/0113894501265769231020031857
|
| 34 |
Laura Pellegrini, Anna Albecka, Donna L. Mallery, Max J. Kellner, David Paul, Andrew P. Carter, Leo C. James, Madeline A. Lancaster. SARS-CoV-2 Infects the Brain Choroid Plexus and Disrupts the Blood-CSF Barrier in Human Brain Organoids. Cell Stem Cell 2020; 27(6): 951 doi: 10.1016/j.stem.2020.10.001
|
| 35 |
Beti Todorovska, Nenad Joksimovic, Viktorija Caloska-Ivanova, Magdalena Dimitrova-Genadieva, Meri Trajkovska, Elena Curakova, Sanja Kiprijanovska, Beti Zafirova-Ivanovska, Vladimir Serafimoski. Factors That Influence the Virological Response in Patients with Chronic Hepatitis C Treated with Pegylated Interferon and Ribavirin. PRILOZI 2017; 38(1): 25 doi: 10.1515/prilozi-2017-0003
|
| 36 |
T.L. Hrydina . PECULIARITIES OF TREATMENT AND PREVENTION OF INFECTION CAUSED BY HEPATITIS C VIRUS. Review. Medical Science of Ukraine (MSU) 2022; 18(1): 64 doi: 10.32345/2664-4738.1.2022.09
|
| 37 |
Miriam Triyatni, Edward A Berger, Bertrand Saunier. Assembly and release of infectious hepatitis C virus involving unusual organization of the secretory pathway. World Journal of Hepatology 2016; 8(19): 796-814 doi: 10.4254/wjh.v8.i19.796
|
| 38 |
Lucy Rivett, Graeme Alexander. Is the conquest of Hepatitis C imminent?. Expert Reviews in Molecular Medicine 2019; 21 doi: 10.1017/erm.2019.3
|
| 39 |
Marina Barriocanal, Puri Fortes. Long Non-coding RNAs in Hepatitis C Virus-Infected Cells. Frontiers in Microbiology 2017; 8 doi: 10.3389/fmicb.2017.01833
|
| 40 |
Simmone D'souza, Keith CK Lau, Carla S Coffin, Trushar R Patel. Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma. World Journal of Gastroenterology 2020; 26(38): 5759-5783 doi: 10.3748/wjg.v26.i38.5759
|
| 41 |
Batbold Batsaikhan, Ching-I Huang, Ming-Lun Yeh, Chung-Feng Huang, Nei-Jen Hou, Zu-Yau Lin, Shinn-Cherng Chen, Jee-Fu Huang, Ming-Lung Yu, Wan-Long Chuang, Jin-Ching Lee, Chia-Yen Dai. The effect of antiviral therapy on serum lipid profiles in chronic hepatitis C. Oncotarget 2018; 9(30): 21313 doi: 10.18632/oncotarget.25092
|
| 42 |
Milad Zandi, Parastoo Hosseini, Saber Soltani, Azadeh Rasooli, Mona Moghadami, Sepideh Nasimzadeh, Farzane Behnezhad. The role of lipids in the pathophysiology of coronavirus infections. Osong Public Health and Research Perspectives 2021; 12(5): 278 doi: 10.24171/j.phrp.2021.0153
|
| 43 |
Kunitada Shimotohno. HCV Assembly and Egress via Modifications in Host Lipid Metabolic Systems. Cold Spring Harbor Perspectives in Medicine 2021; 11(1): a036814 doi: 10.1101/cshperspect.a036814
|